Pharma: Novartis shares fell 10%, marking the company's potential worst day ever, following three setbacks in drug trials.
Novartis shares plummeted on Tuesday following disappointing results from its del-desiran drug trial, leaving investors anxious. Stay tuned for updates on how this will impact the company's future! #Novartis #PharmaNews
What's Your Reaction?
Like
0
Dislike
0
Love
0
Funny
0
Angry
0
Sad
0
Wow
0
